AMT three-lens brief
Evidence-based stock research on AMT. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 8.1pp over 30 days. · Debt-to-equity of 434.2 — balance-sheet-heavy.
- Underperforming SPY by 8.1pp over 30 days.
- Analyst mean target $215.45 — 21% above current (22 analysts).
- Debt-to-equity of 434.2 — balance-sheet-heavy.
- Earnings in 3 days (2026-04-28).
AMT closed at $178.21 (-0.45%) as of 2026-04-25. Market cap: $83.11B. P/E (trailing) 33.0. Positives: analyst mean target $215.45 — 21% above current (22 analysts).. Concerns: underperforming SPY by 8.1pp over 30 days.; debt-to-equity of 434.2 — balance-sheet-heavy.. Last quarter: Revenue $2.74B, net income $820.70M, free cash flow $4.51B. Watching for: 2026-04-28 earnings release (3 days out).
Why three lenses on AMT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMTacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMT brief"></iframe>